Conjugate vaccines are a vital tool in preventing various infectious diseases by utilizing a combination of a weak antigen with a strong one, enhancing the immune response. This type of vaccine is particularly effective against bacterial infections like pneumococcal diseases, meningococcal infections, and Haemophilus influenzae type b (Hib). By linking a protein antigen to a polysaccharide antigen, conjugate vaccines prompt a robust immune reaction, especially in infants and young children who might not respond adequately to polysaccharide antigens alone. These vaccines play a crucial role in safeguarding vulnerable populations, reducing the spread of diseases, and preventing severe complications caused by certain bacteria, contributing significantly to public health worldwide.
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination
Vincenzo Alfano, University of Napoli Parthenope, Italy
Title : Neutralizing antibodies response to SARS-COV-2 XBB1.5 mRNA vaccine in nephrology patients on dialysis against different viral variants
Agostino Riva, University of Milan, Italy
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : The influence of physical factors on recombinant human serum albumin
Patrycja Dolibog, Medical University of Silesia in Katowice, Poland
Title : Current investments and future directions of biomedical advanced research and development authority’s CBRN vaccines portfolio
Lindsay Parish, BARDA, United States
Title : Development and characterization of a virus-like particle-based subunit vaccine candidate against Indian isolate of Porcine Circovirus 2d
Rajib Deb, ICAR-National Research Centre on Pig, India
Title : The Ethiopian vaccine supply chain and logistics system’s performance after the last mile delivery initiative: Phenomenological study
Samson Gebremedhin Gebreselassie, Project HOPE, Ethiopia
Title : Limits of vaccine quality control in India: Possible solutions
Bhoj R Singh, Indian Veterinary Research Institute, India